학술논문
P83.02 Niraparib + Pembrolizumab (Pembro) Versus Placebo + Pembro 1L Maintenance Therapy in Advanced NSCLC: ZEAL-1L Phase III Study
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology March 2021 16(3) Supplement:S653-S654
Subject
Language
ISSN
1556-0864